The Chemours Company (CC)
NYSE: CC · Real-Time Price · USD
15.18
-0.06 (-0.39%)
Aug 13, 2026, 2:31 PM EDT - Market open
The Chemours Company Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 671 | 670 | 713 | 1,203 | 1,102 | 1,451 |
Cash & Short-Term Investments | 671 | 670 | 713 | 1,203 | 1,102 | 1,451 |
Cash Growth | 33.66% | -6.03% | -40.73% | 9.16% | -24.05% | 31.31% |
Accounts Receivable | 907 | 679 | 770 | 610 | 626 | 720 |
Inventory | 1,452 | 1,569 | 1,463 | 1,352 | 1,404 | 1,099 |
Other Current Assets | 64 | 83 | 71 | 670 | 82 | 75 |
Total Current Assets | 3,094 | 3,001 | 3,017 | 3,835 | 3,214 | 3,345 |
Net Property, Plant & Equipment | 3,028 | 3,078 | 3,188 | 3,216 | 3,171 | 3,154 |
Other Intangible Assets | 2 | 2 | 3 | 3 | 13 | 6 |
Goodwill | 46 | 46 | 46 | 102 | 102 | 102 |
Long-Term Investments | 170 | 160 | 152 | 158 | 175 | 169 |
Other Long-Term Assets | 540 | 824 | 838 | 677 | 725 | 547 |
Total Assets | 7,150 | 7,382 | 7,509 | 8,251 | 7,640 | 7,550 |
Accounts Payable | 937 | 954 | 1,156 | 1,159 | 1,233 | 1,162 |
Accrued Expenses | 890 | 690 | 610 | 1,276 | 615 | 671 |
Current Portion of Long-Term Debt | 34 | 42 | 54 | 51 | 43 | 25 |
Total Current Liabilities | 1,861 | 1,686 | 1,820 | 2,486 | 1,891 | 1,858 |
Long-Term Debt | 3,838 | 4,099 | 4,059 | 3,987 | 3,590 | 3,724 |
Long-Term Leases | 461 | 462 | 463 | 466 | 438 | 406 |
Other Long-Term Liabilities | 1,308 | 1,155 | 860 | 833 | 854 | 707 |
Total Long-Term Liabilities | 5,607 | 5,716 | 5,382 | 5,286 | 4,882 | 4,837 |
Total Liabilities | 7,198 | 7,131 | 6,937 | 7,512 | 6,533 | 6,468 |
Common Stock | 2 | 2 | 2 | 2 | 2 | 2 |
Treasury Stock | -1,801 | -1,802 | -1,804 | -1,806 | -1,738 | -1,247 |
Additional Paid-in Capital | 1,088 | 1,074 | 1,055 | 1,033 | 1,016 | 944 |
Accumulated Other Comprehensive Income | -229 | -244 | -367 | -274 | -343 | -364 |
Retained Earnings | 891 | 1,220 | 1,685 | 1,782 | 2,170 | 1,746 |
Total Common Shareholders' Equity | -49 | 250 | 571 | 737 | 1,107 | 1,081 |
Minority Interest | 1 | 1 | 1 | 2 | - | 1 |
Shareholders' Equity | -48 | 251 | 572 | 739 | 1,107 | 1,082 |
Total Liabilities & Equity | 7,150 | 7,382 | 7,509 | 8,251 | 7,640 | 7,550 |
Total Debt | 4,333 | 4,603 | 4,576 | 4,504 | 4,071 | 4,155 |
Net Cash (Debt) | -3,662 | -3,933 | -3,863 | -3,301 | -2,969 | -2,704 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -24.27 | -26.18 | -25.72 | -22.17 | -18.75 | -16.01 |
Book Value | -49 | 250 | 571 | 737 | 1,107 | 1,081 |
Book Value Per Share | -0.32 | 1.66 | 3.80 | 4.95 | 6.99 | 6.40 |
Tangible Book Value | -97 | 202 | 522 | 632 | 992 | 973 |
Tangible Book Value Per Share | -0.64 | 1.34 | 3.48 | 4.24 | 6.27 | 5.76 |